Volta Labs
MA - BostonBiotechnology
Focus: Volta Labs develops genomic sample preparation technology enabling automated library prep for next-generation sequencing platforms, with current focus on Oxford Nanopore applications. The company operates as a pre-revenue biotech tool/infrastructure provider serving the genomic research and clinical diagnostics markets.
Profile data last refreshed 12h ago · AI intelligence enriched 3w ago
Open Jobs
1-5 this month
Cooling — net -5 jobs in 30d
0 added, 5 removed. Slower than typical.
Should You Work at Volta Labs?
AI assessmentEarly-stage tool company with promising technology and recent execution, but pre-revenue status and opaque financial/funding position make it suitable only for risk-tolerant candidates seeking equity upside and deep technical ownership.
Why Work Here
- Ground-floor opportunity at an early-stage genomics infrastructure company with recent product launch (May 2026) demonstrating technical execution capability.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Volta Labs
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.